PHC Holdings Corporation
PHC Holdings Corporation Second Quarter (Interim) Financial Summary [IFRS] (Consolidated)
For the second quarter of the fiscal year ending March 2027, consolidated revenue was 179,970 million yen (Year-over-Year 3.8% increase), operating income was 19,439 million yen (Year-over-Year 87.3% increase), and interim profit was 13,313 million yen. The full-year earnings guidance was revised. By segment, Diabetes Management and Diagnostics & Life Sciences were robust, while Healthcare Solutions was a detractor to profit.
Key Figures
- Revenue: 179,970 million yen (Year-over-Year 3.8% increase)
- Operating Income: 19,439 million yen (Year-over-Year 87.3% increase)
- Interim Profit Attributable to Owners of Parent: 13,313 million yen
AI要約
Key Points of Results
In the second quarter of the fiscal year ending March 2027, PHC Holdings Corporation reported consolidated revenue of 179,970 million yen, a 3.8% increase year-over-year, and operating income of 19,439 million yen, a substantial improvement. By segment, Diabetes Management and Diagnostics & Life Sciences drove revenue and profit growth, while Healthcare Solutions experienced profit decline. The full-year earnings guidance was revised to reflect foreign exchange effects and anticipated cost reduction benefits.
Outlook and Impact
The revision to the full-year forecast reflects strong first-half performance while incorporating lower sales in Healthcare IT Solutions, resulting in divergent profit outlooks by segment. Attention should be paid to fluctuations in adjusted EBITDA that include foreign exchange impacts and one-time items related to M&A. This document does not include explicit statements on shareholder returns or capital policy.
PHC Holdings Corporation
Company overview · Stock price · Financial data · All IR
